SCN5A Variant V95L

Summary of observed carriers, functional annotations, and structural context for SCN5A V95L. Data combine curated literature, international cohorts, and gnomAD observations.

Estimated LQT3 penetrance

1%

0/16 effective observations

Estimated BrS1 penetrance

11%

1/16 effective observations

Total carriers

6

0 BrS1 · 0 LQT3 · 6 unaffected

V95L is present in 6 alleles in gnomAD. This residue resides in a Mild_Hotspot region for Brugada syndrome and a Non_Hotspot region for LQT3.

Variant features alone are equivalent to phenotyping 1 individuals for Brugada syndrome and 0 individuals for LQT3.

In silico predictors

Variant-level computational predictors.
PROVEAN PolyPhen-2 BLAST-PSSM REVEL Penetrance Density BrS (%) Penetrance Density LQT3 (%)
-2.84 0.997 -0.77 0.869 19 2

PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).

Reported carrier data

Observed carriers by publication or cohort.
Source Year Carriers Unaffected LQT3 BrS1 Other Other Disease
Literature, cohort, and gnomAD – 6 6 0 0 –
Variant features alone – 15 14 0 1 – –

Totals may differ from individual publications due to duplicate patients removed during curation.

Nearby variants

Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.

Previously observed variants near V95L.
Neighbour residue Distance (Å) Observed variants
80 15
81 14
82 14 D82E, D82E,
83 13 p.L83WfsX14,
84 13 D84G, D84N,
85 12 P85T, P85S,
86 11 F86L, F86L, F86L,
87 11 Y87C,
88 10 S88G,
89 9
90 8 p.Q90WfsX14,
91 8
92 7 T92I, c.274-24C>T,
93 5 F93S,
94 4 I94S, I94V,
95 0 V95I, V95L, V95L,
96 4
97 5
98 7
99 8
100 8
101 9 T101I,
102 10
103 11
104 11 R104Q, R104G, R104W,
105 12
106 13 S106T,
107 13
108 14
109 14 N109K, N109K,
110 15 A110T,